This ties in with the unique presentation of the clot concerned doesn’t it?
My understanding is that the particular clot that sparked concern was associated with blood thinning. One theory (?) is that the body is trying to compensate for thin blood and over produced platelets which in turn then caused the clots. It’s similar to a phenomenon seen with a blood thinning medication, heparin I believe, and I think treatment protocols have been identified as being the same.
On the plus side these side effects are being identified (and still very rare otherwise they would have come up in large numbers at the trial stage) so clinicians know what they’re looking for and how to treat.
I agree that transparency is great as the general public we need to recognise that we don’t actually understand a lot of what we’re being told. That’s fine, we can’t all be highly educated pharmacologists and scientists, but it’s important to remember that our perspective isn’t informed or balanced.
I keep on with this comparison but it took decades to identify a problem with aspirin and children. If we’d had cause to give every child in the country aspirin at some point in today’s climate it probably would have been banned completely when clearly it has many benefits and doesn’t warrant that kind of over reaction at all.